Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
We present a short assessment based on a critical selection of evidence indicating nanotechnology's promise in the prevention and treatment of respiratory infections.PMID:34721558 | PMC:PMC8550859 | DOI:10.1155/2021/6741290
Source: PPAR Research - Category: Genetics & Stem Cells Authors: Mahdi Ftouh Nesrine Kalboussi Nabil Abid Souad Sfar Nathalie Mignet Badr Bahloul Source Type: research
More News: Adenoviruses | Centers for Disease Control and Prevention (CDC) | Coronavirus | COVID-19 | Depression | Epidemics | Epidemiology | Flu Pandemic | Genetics | Influenza | Influenza Vaccine | Nanotechnology | Pandemics | Respiratory Medicine | SARS | Vaccines